This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016;17(4):457-61.

doi: 10.1517/14656566.2016.1146686. Epub 2016 Feb 15.

Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

Francesco Panza^{1

2

3}, Davide Seripa³, Vincenzo Solfrizzi⁴, Bruno P Imbimbo⁵, Andrea Santamato⁶, Madia Lozupone¹, Rosa Capozzo^{1

2}, Camilla Prete⁷, Alberto Pilotto⁷, Antonio Greco³, Giancarlo Logroscino^{1

2}

Affiliations

Affiliations

¹ a Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs , University of Bari Aldo Moro , Bari , Italy.
² b Department of Clinical Research in Neurology , University of Bari Aldo Moro, 'Pia Fondazione Cardinale G. Panico' , Lecce , Italy.
³ c Geriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences , IRCCS 'Casa Sollievo della Sofferenza' , Foggia , Italy.
⁴ d Geriatric Medicine-Memory Unit and Rare Disease Centre , University of Bari Aldo Moro , Bari , Italy.
⁵ e Research & Development Department , Chiesi Farmaceutici , Parma , Italy.
⁶ f Physical Medicine and Rehabilitation Section, 'OORR' Hospital , University of Foggia , Foggia , Italy.
⁷ g Department of OrthoGeriatrics, Rehabilitation and Stabilization, Frailty Area , E.O. Galliera NR-HS Hospital , Genova , Italy.

PMID: 26809554
DOI: 10.1517/14656566.2016.1146686

Editorial

Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

Francesco Panza et al. Expert Opin Pharmacother. 2016.

. 2016;17(4):457-61.

doi: 10.1517/14656566.2016.1146686. Epub 2016 Feb 15.

Authors

Francesco Panza^{1

2

3}, Davide Seripa³, Vincenzo Solfrizzi⁴, Bruno P Imbimbo⁵, Andrea Santamato⁶, Madia Lozupone¹, Rosa Capozzo^{1

2}, Camilla Prete⁷, Alberto Pilotto⁷, Antonio Greco³, Giancarlo Logroscino^{1

2}

Affiliations

¹ a Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs , University of Bari Aldo Moro , Bari , Italy.
² b Department of Clinical Research in Neurology , University of Bari Aldo Moro, 'Pia Fondazione Cardinale G. Panico' , Lecce , Italy.
³ c Geriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences , IRCCS 'Casa Sollievo della Sofferenza' , Foggia , Italy.
⁴ d Geriatric Medicine-Memory Unit and Rare Disease Centre , University of Bari Aldo Moro , Bari , Italy.
⁵ e Research & Development Department , Chiesi Farmaceutici , Parma , Italy.
⁶ f Physical Medicine and Rehabilitation Section, 'OORR' Hospital , University of Foggia , Foggia , Italy.
⁷ g Department of OrthoGeriatrics, Rehabilitation and Stabilization, Frailty Area , E.O. Galliera NR-HS Hospital , Genova , Italy.

PMID: 26809554
DOI: 10.1517/14656566.2016.1146686

No abstract available

PubMed Disclaimer

Publication types

Actions
Actions

LinkOut - more resources

Other Literature Sources
- scite Smart Citations